Volume 17, Number 2—February 2011
Research
Severe Cases of Pandemic (H1N1) 2009 in Children, Germany
Mathias Altmann
, Lena Fiebig, Jana Soyka, Rüdiger von Kries, Manuel Dehnert, and Walter Haas
, Lena Fiebig, Jana Soyka, Rüdiger von Kries, Manuel Dehnert, and Walter Haas
Table 2
Clinical diagnosis for children with severe pandemic (H1N1) 2009, Germany, 2009–2010*
| Clinical diagnosis | Total† | Nonsurvivors not in PICU† | Admitted to PICU |
||||
|---|---|---|---|---|---|---|---|
| Survivors† | Nonsurvivors† | Subtotal† | p value | OR (95% CI) | |||
| Pneumonia | 70/93 (75) | 4/4 (100) | 59/78 (76) | 7/11 (64) | 66/89 (74) | 0.465 | 0.6 (0.1–2.9) |
| ARDS | 22/93 (24) | 0/4 (0) | 15/78 (19) | 7/11 (64) | 22/89 (25) | 0.004 | 7.4 (1.6–37.8) |
| Secondary pneumonia | 15/93 (16) | 0/4 (0) | 13/78 (17) | 2/11 (18) | 15/89 (17) | 1 | 1.1 (0.1–6.3) |
| Bronchitis/bronchiolitis | 12/93 (13) | 1/4 (25) | 10/78 (13) | 1/11 (9) | 11/89 (12) | 1 | 0.7 (0.0–5.8) |
| Encephalopathy | 6/93 (6) | 0/4 (0) | 5/78 (6) | 1/11 (9) | 6/89 (7) | 0.558 | 1.5 (0.0–15.1) |
| Sepsis | 6/93 (6) | 1/4 (25) | 5/78 (6) | 0/11 (0) | 5/89 (6) | 1 | 0.0 (0.0–5.6) |
| Status asthmaticus | 2/93 (2) | 0/4 (0) | 2/78 (3) | 0/11 (0) | 2/89 (2) | 1 | 0.0 (0.0–14.5) |
| Febrile seizure | 2/93 (2) | 0/4 (0) | 2/78 (3) | 0/11 (0) | 2/89 (2) | 1 | 0.0 (0.0–14.5) |
| Myocarditis | 2/93 (2) | 0/4 (0) | 1/78 (1) | 1/11 (9) | 2/89 (2) | 0.233 | 7.7 (0.1–611.9) |
| Other diagnosis‡ | 26/93 (28) | 0/4 (0) | 21/78 (27) | 5/11 (45) | 26/89 (29) | 0.287 | 2.3 (0.5–9.9) |
*Values are no. positive/no. with available information (%) except as indicated. PICU, pediatric intensive care unit; OR, odds ratio; CI, confidence interval; ARDS, acute respiratory distress syndrome. ORs were calculated only among the cases admitted to the PICU.
†Children may have had >1 diagnosis.
‡Acute exacerbation of a chronic disease or new diagnosis.
Page created: July 13, 2011
Page updated: July 13, 2011
Page reviewed: July 13, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.